ABSTRACT
as they try to address the multitude of problems, which can occur in a wound. We demand a lot from dressings expecting them to speed up the healing process, reduce pain, prevent infection, absorb untold quantities of exudate, minimize odour and hide the wound from the patient. Furthermore it needs to stay intact until we want to remove it without causing complications at the wound and peri-wound regions. Studies have shown that pain, odour and exudate are the most important elements of a chronic wound which impact directly on a patient's quality of life (Vowden and Vowden, 2003) . If we can get a dressing that does all of the above we will have a confident clinician and more importantly a confident patient. A positive attitude in a patient is essential to drive the healing process forward.
Emotions in wound healing
Emotions can affect the body's response to illness and recovery. Studies have shown that stress and anxiety can slow down wound healing and impede recovery from surgery (Liu et aI, 1994; Dyson et aI, 2003 and Ebrecht et aI, 2004) . Other studies have shown significant improvements can be produced on various components of post-operative recovery following positive pre-operative psychological interventions (Weinman and Johnston, 1988) . It has been shown that patients' expectations can have a clear effect on wound healing (McCarthy et aI, 2003) .Therefore, it should be the aim of every clinician to create not only the correct physical and physiological environment around and in the wound itself but also the correct psychological environment within the patient.
It is important to identifY the common sources of stress and anxiety in patients who are undergoing an episode of wound care. Stress is likely to occur mainly at two stages, the period leading up to dressing change and during the dressing change itself. In the period leading up to dressing change the stress could be due to leakage of exudate, the dressing becoming loose, discolouration of the dressing, odour, and also anticipatory thoughts of wound manipulation associated with the upcoming dressing change. Discomfort can often be associated with the dressing change itself, wound cleansing or irrigation, and the effects of the ambient environment-heat loss, desiccation-on the wound surface during assessment and treatment.
Depression is a common factor of patients with chronic health conditions, including chronic pain and chronic wounds. Restoring trust can be exceedingly difficult because of the negative expectations of patient and clinician.
The gold standard in wound dressings e.g. the one that gives patients that feeling of comfort, security, confidence, would be one that is easy to apply, is a once only application and stays in perfect condition until the wound is fully healed. Ideally the patient would want a 'dress and forget' approach to wound management. In the absence of such a 'perfect' dressing we have to make a choice from the many dressings that are available now to us. It is also important to remember that when applying a dressing to a wound you are also making contact with the skin around it so an assessment of the patients' skin is essential.
This paper discusses the results of a non-comparative study where users were asked to evaluate four technically MVTR is the measure of fluid that is passed through a film membrane-often incorporated within dressings-during a given period of time. The MVTR will be determined by the molecular structure of the membrane, which once hydrated from contact with liquid will facilitate moisture transportation and as such will determine the level of excess fluid that is passed away from the dressing. It is important to note that the technology incorporated within new ALLEVYN ensures that only excess moisture is passed through the dressing, leaving a level of moisture on the wound bed to promote the optimum wound environment and faster healing. MVTR is a continual process whereas handling of fluid through absorption is a one off event, therefore once the absorption capacity of a dressing has been reached then no further fluid handling can take place. The effective management of exudate through a combination of absorption and a high MVTR can reduce pooling at the skin surface, which has the potential to cause maceration, or leakage, which may allow the penetration of bacteria to the wound. It may also provide greater comfort and acceptability for patients due to a less saturated and bulky dressing. Data from moisture vapour transmission rate (MVTR) tests show that the fluid handling characteristics of the new dressings have been enhanced considerably. The MVTR of the adhesive dressings has been improved by 534%, while the MVTR of the non-adhesive dressings has been improved by 915% (Figure 1 ).
The Allevyn range is able to do this because of the enhancements to its trilaminate structure (Williams, 1995) . The dressings now have polyethylene glycol within the hydro cellular core to give faster fluid uptake. In addition to this they also exploit IV3000 film technology, which gives the dressings the enhanced transpiration/evaporation rates (Williams, 2005) .
How is moisture resistance measured?
Moisture resistance is measured in a special chamber, divided vertically by the substrate or barrier material. A dry atmosphere is in one chamber, and a moist atmosphere is in the other. A 24-hour test is run to see how much moisture passes through the substrate or barrier from the 'wet' chamber to the' dry' chamber. Standard test procedures can specifY anyone of five combinations of temperature and humidity in the 'wet' chamber. The toughest conditions are 100°F / 95%RH (Relative Humidity).
Method Study design
This study was non-comparative looking at the performance of the enhanced dressings. The dressings were applied to low to heavily exuding wounds.
Primary objective
The user was asked to rate the overall acceptability of the enhanced dressings. This was in the form of one question in the case report form (CRF). The patient had to say YES or NO to the question: 'Is the dressing acceptable for the indication?'
Secondary objectives
The user was asked to assess the following aspects of the enhanced dressings against that of the users experience with the original Allevyn dressings:
Appearance, conformability, dressing fixation (adhesive variant), absorbency and wear time. For each attribute the patient had to indicate whether the new dressing 
level of acceptability
Prior to the evaluation starting, guidelines were set up to help assess the level of acceptability. The limit set for the acceptability criteria was at least 75% of the patient responses reporting YES it is acceptable. Acceptable wound and peri-wound complications were set within the statistical considerations.
Less than 25% of the responses needed to be severe and less than 50% needed to be moderate or severe.
Results

Primary objective
Of all the respodents 113 (94%) stated that the dressing was acceptable for the indication while only 7 respondents (6%) said it was not acceptable. Of all the patients taking part in the trial only 1 patient reported an attribute as being worse. This patient reported conformability as being slightly worse and appearance as being worse. The rest of the patients rated the dressing as being as good as the original. Level of wound bed complications on dressing removal (94%) of all dressing removals showed no wound bed complications, indeed 5.25% showed minor wound bed complications.
Secondary objectives
In the study 0.75% did not respond to the question. Of a total of 386 dressing changes there were no reports of severe complications to the wound bed.
Peri-wound complications
The chart in figure 3 indicates the level of complications to peri-wound skin on dressing removal: In total 3 patients gave no response to the question (0.75%). Of all dressing removals 88.75% showed no peri-wound complications with 10.25% showing minor peri-wound complications. Finally 0.25% indicated severe complications.
One patient reported an allergic response after removing Allevyn
Adhesive dressing, but it was not classed as serious.
Conclusion
The results show that the dressing was acceptable for the indication used in 94% of the patients and not acceptable in 6% of the sample studied. This figure should, however, be viewed with caution, several of the patients within this sub group gave no reasonable explanation as to why they found the dressing unacceptable. Since the limit set for the acceptability criteria was 75% of the responses reporting YES , it can be concluded that this criterion was met. With regard to wound bed complications, 94% reported no complications at dressing removal. Only 5.25% reported minor complications at the wound site upon dressing removal. Of the sample 0.75% gave no response to the question. Therefore the above criterion set was well met and there was no concern that the modifications to the evaluation dressing will have a detrimental effect on the wound.
In the evaluation 88.75% reported no peri-wound complications at dressing removal while 10.25% reported minor complications to the surrounding skin upon dressing removal. One patient reported severe complications to the surrounding skin, 0.75% gave no response to the question. fixative' properties. In the introduction the importance of patient comfort and confidence was stressed. This trial has looked at many aspects of the new wound dressing, which addresses patient concerns.
In terms of comfort, i.e. conformability and adherence, the new dressing rated well by patients and staff alike. The enhanced comfort means that the patients will not be thinking constantly about their wound. This reduces the anxiety the patient has and leads
KEY POINTS
+rhe enhanced fluid management profile of the Allevyn dressings has led to an increase in the patients feeling of comfort, security and confidence. The enhancements equate to a reduction in dressing changes, whIch benefits patient, clinicfan and bUdget holder. +rhe enhanced comfort means that the patients will not be thinking cOnstantly about their wound A patient with less anxiety leads to greater cOmpliance with the care plan.
to greater compliance with the care plan.
Also in the introduction the gold standard of wound dressings was talked about as being one that enables you to dress and forget, a once only application, because it manages the wound leaving the patient to get on with their lives. The enhancements now present in new Allevyn facilitate a faster uptake of fluid, and perhaps more importantly the 'intelligent' breathable top film, allows for greater rate of moisture vapour transpiration. The process and dynamics of exudate management is evolving from one based solely on absorption to one of controlled fluid management. The above-mentioned enhancements equate to a reduction in dressing changes, which benefits patient, clinician and budget holder.
Finally, the performance of the new enhanced Allevyn dressings appears to reassure patients by creating not only the correct physical and physiological environment in and around the wound itself, furthermore it facilitates the correct psychological environment for the patient, which equates to an enhanced wound healing episode. BJCN
